Santhera Pharmaceuticals Holding AG (SPHDF PINK) stock market data APIs
$23.3344
0(0%)
as of June 12, 2026
Try our APIs with
free plan!
Santhera Pharmaceuticals Holding AG Financial Data Overview
Price chart is built with
Anychart
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Prev. Close
23.3344
Open
23.3344
High
23.3344
Low
23.3344
52 wk Range
12.275-23.25
Market Cap
345 M
Shares Outstanding
14 831 K
Revenue
77 185 K
EPS
-0.4985
Beta
-0.314
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Santhera Pharmaceuticals Holding AG data using free add-ons & libraries
Get Santhera Pharmaceuticals Holding AG Fundamental Data
Santhera Pharmaceuticals Holding AG Fundamental data includes:
- Net Revenue: 77 185 K
- EBITDA: -32 536 000
- Earnings Per Share: -4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Santhera Pharmaceuticals Holding AG Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
Get Santhera Pharmaceuticals Holding AG End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Santhera Pharmaceuticals Holding AG News
New
Santhera Moves Closer To Earlier Treatment Access For Young DMD Patients In Europe
(RTTNews) - Santhera Pharmaceuticals (SANN) has received a positive opinion from the European Medicines Agency's CHMP to expand the use of AGAMREE (vamorolone) to children with Duchenne muscular dystr...
Santhera Pharma Appoints Marc Clausse As Chief Commercial Officer
(RTTNews) - Santhera Pharmaceuticals Holding AG (SANN.SW, SPHDF), a Swiss specialty pharmaceutical company, on Tuesday appointed Marc Clausse as Chief Commercial Officer effective June 1. Chief Comme...
Santhera Appoints Stifel as Corporate Finance Advisor
Santhera Pharmaceuticals Holding AG Pratteln, Switzerland, February 10, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced the appointment of Stifel Nicolaus Europe Limited (“Stifel”) ...
Swissmedic Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy
(RTTNews) - Santhera Pharmaceuticals (SANN.SW, SPHDF) announced that the Swiss Agency for Therapeutic Products (Swissmedic) has approved AGAMREE (vamorolone) for the treatment of Duchenne muscular dys...
Get Santhera Pharmaceuticals Holding AG fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
